Recent Posts
-
AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF
MYHIBBIN™ (mycophenolate mofetil oral suspension) -
Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of
Zenzedi® (dextroamphetamine sulfate tablets, USP) 30 mg Due to a Mislabeled Package During Manufacturing - Azurity Pharmaceuticals Acquires Slayback Pharma
- AZURITY PHARMACEUTICALS, INC. ANNOUNCES U.S. AVAILABILITY OF ZONISADE™ (zonisamide oral suspension)
- AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF KONVOMEP™ (omeprazole and sodium bicarbonate for oral suspension)
Recent Comments